Heritage Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $397K | Sell |
6,545
-356
| -5% | -$20.8K | 0.04% | 236 |
|
|
2025
Q4 | $372K | Sell |
6,901
-18,136
| -72% | -$872K | 0.04% | 240 |
|
|
2025
Q3 | $1.13M | Sell |
25,037
-250
| -1% | -$11.7K | 0.12% | 162 |
|
|
2025
Q2 | $1.17M | Hold |
25,287
| – | – | 0.14% | 150 |
|
|
2025
Q1 | $1.54M | Buy |
25,287
+3,833
| +18% | +$223K | 0.19% | 126 |
|
|
2024
Q4 | $1.21M | Buy |
+21,454
| New | +$1.2M | 0.14% | 141 |
|
|
2024
Q2 | $348K | Sell |
8,384
-104
| -1% | -$4.65K | 0.05% | 226 |
|
|
2024
Q1 | $460K | Sell |
8,488
-1,898
| -18% | -$96.7K | 0.06% | 195 |
|
|
2023
Q4 | $533K | Sell |
10,386
-27,889
| -73% | -$1.46M | 0.08% | 188 |
|
|
2023
Q3 | $2.22M | Sell |
38,275
-47
| -0.1% | -$2.88K | 0.35% | 79 |
|
|
2023
Q2 | $2.45M | Buy |
38,322
+2,542
| +7% | +$170K | 0.36% | 78 |
|
|
2023
Q1 | $2.48M | Buy |
35,780
+2,669
| +8% | +$188K | 0.39% | 77 |
|
|
2022
Q4 | $2.38M | Buy |
33,111
+3,856
| +13% | +$291K | 0.39% | 81 |
|
|
2022
Q3 | $2.08M | Sell |
29,255
-16
| -0.1% | -$1.16K | 0.36% | 78 |
|
|
2022
Q2 | $2.25M | Buy |
29,271
+575
| +2% | +$43.8K | 0.37% | 77 |
|
|
2022
Q1 | $2.1M | Buy |
28,696
+19,406
| +209% | +$1.3M | 0.3% | 90 |
|
|
2021
Q4 | $579K | Buy |
9,290
+578
| +7% | +$33.9K | 0.07% | 176 |
|
|
2021
Q3 | $516K | Buy |
8,712
+188
| +2% | +$12.4K | 0.07% | 177 |
|
|
2021
Q2 | $570K | Buy |
8,524
+885
| +12% | +$57.7K | 0.08% | 170 |
|
|
2021
Q1 | $482K | Sell |
7,639
-6,488
| -46% | -$404K | 0.07% | 173 |
|
|
2020
Q4 | $876K | Buy |
14,127
+301
| +2% | +$18.5K | 0.14% | 131 |
|
|
2020
Q3 | $833K | Sell |
13,826
-2,472
| -15% | -$149K | 0.16% | 118 |
|
|
2020
Q2 | $958K | Buy |
16,298
+9,006
| +124% | +$539K | 0.19% | 107 |
|
|
2020
Q1 | $406K | Buy |
7,292
+6
| +0.1% | +$367 | 0.1% | 132 |
|
|
2019
Q4 | $468K | Buy |
+7,286
| New | +$417K | 0.09% | 140 |
|
|
2019
Q1 | – | Sell |
-1,500
| Closed | -$78K | – | 208 |
|
|
2018
Q4 | $78K | Sell |
1,500
-193
| -11% | -$10.4K | 0.03% | 178 |
|
|
2018
Q3 | $105K | Hold |
1,693
| – | – | 0.04% | 164 |
|
|
2018
Q2 | $94K | Sell |
1,693
-190
| -10% | -$10.3K | 0.04% | 163 |
|
|
2018
Q1 | $119K | Hold |
1,883
| – | – | 0.04% | 144 |
|
|
2017
Q4 | $115K | Sell |
1,883
-14
| -0.7% | -$876 | 0.04% | 139 |
|
|
2017
Q3 | $121K | Buy |
1,897
+100
| +6% | +$5.84K | 0.04% | 137 |
|
|
2017
Q2 | $100K | Sell |
1,797
-465
| -21% | -$25.3K | 0.04% | 143 |
|
|
2017
Q1 | $123K | Buy |
+2,262
| New | +$124K | 0.05% | 134 |
|
Other funds holding BMY
VCM
VPM
Heritage Trust's BMY Position: Q1 2026 in Review
Heritage Trust reduced its Bristol-Myers Squibb (BMY) stake by 5.2% in Q1 2026, selling an estimated $20.8K and leaving 6,545 shares worth $397K. The position accounts for 0.04% of the portfolio, ranked #236.
Heritage Trust first reported a position in BMY in Q1 2017 and has held it in 33 quarters since. The position peaked at $2.48M in Q1 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Heritage Trust held 6,545 shares of Bristol-Myers Squibb worth $397K as of Q1 2026.
- Heritage Trust sold 356 Bristol-Myers Squibb shares in Q1 2026, an estimated $20.8K.
- Bristol-Myers Squibb made up 0.04% of Heritage Trust's portfolio in Q1 2026, its #236 holding.
- Heritage Trust first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 33 quarters since.
- Heritage Trust's Bristol-Myers Squibb position peaked at $2.48M in Q1 2023.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Heritage Trust's 13F filing for Q1 2026, filed 13 May 2026.